Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α

Piceatannol (PIC) is known to have anticancer activity, which has been attributed to its ability to block the proliferation of cancer cells via suppression of the NF-kB signaling pathway. However, its effect on hypoxia-inducible factor (HIF) is not well known in cancer. In this study, PIC was loaded...

Descripción completa

Detalles Bibliográficos
Autores principales: A. A. Aljabali, Alaa, A. Bakshi, Hamid, L. Hakkim, Faruck, Haggag, Yusuf A., M. Al-Batanyeh, Khalid, S. Al Zoubi, Mazhar, Al-Trad, Bahaa, M. Nasef, Mohamed, Satija, Saurabh, Mehta, Meenu, Pabreja, Kavita, Mishra, Vijay, Khan, Mohammed, Abobaker, Salem, M. Azzouz, Ibrahim, Dureja, Harish, M. Pabari, Ritesh, Ali K. Dardouri, Ashref, Kesharwani, Prashant, Gupta, Gaurav, Dhar Shukla, Shakti, Prasher, Parteek, B. Charbe, Nitin, Negi, Poonam, N. Kapoor, Deepak, Chellappan, Dinesh Kumar, Webba da Silva, Mateus, Thompson, Paul, Dua, Kamal, McCarron, Paul, M. Tambuwala, Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017258/
https://www.ncbi.nlm.nih.gov/pubmed/31906321
http://dx.doi.org/10.3390/cancers12010113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017258/
https://www.ncbi.nlm.nih.gov/pubmed/31906321
http://dx.doi.org/10.3390/cancers12010113

Ejemplares similares